Minimally invasive colorectal resection is associated with a transient increase in plasma hepatocyte growth factor levels early after surgery for colon cancer

Surgical Innovation

Volumn 18, Issue 3, 2011, Pages 254-258

  Kumara, H M C Shantha ^a   Tohme, Samer T ^a   Kim, Ik Y ^b   Kim, Donald G ^c   Kalady, Matthew F ^d   Luchtefeld, Martin ^c   Hoffman, Keith ^a   Dimaggio, Vincent ^a   Whelan, Richard L ^a,e  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b Yonsei University Wonju   (South Korea)

^c Ferguson Clinic   (United States)

^d Digestive Disease Institute   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

colon cancer; colorectal resection; hepatocyte growth factor; surgery related plasma alterations

Indexed keywords

SCATTER FACTOR;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; COLON CANCER; COLON RESECTION; COLORECTAL SURGERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; ILEUS; LAPAROTOMY; LENGTH OF STAY; MALE; MINIMAL RESIDUAL DISEASE; MINIMALLY INVASIVE SURGERY; OPERATION DURATION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; SIGMOIDECTOMY; SURGICAL INFECTION; TUMOR GROWTH; URINE RETENTION;

COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; LAPAROSCOPY; LENGTH OF STAY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, MINIMALLY INVASIVE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 82955228120     PISSN: 15533506     EISSN: 15533514     Source Type: Journal    
DOI: 10.1177/1553350611399588     Document Type: Article

References (31)

1. Bird NC, Mangnall D, Majeed AW. Biology of colorectal liver metastases: a review. J Surg Oncol. 2006 ; 94: 68-80 (Pubitemid 43967727)
2. Leather AJ, Gallegos NC, Kocjan G, et al. Detection and enumeration of circulating tumour cells in colorectal cancer. Br J Surg. 1993 ; 80: 777-780 (Pubitemid 23197741)
3. Allendorf JD, Bessler M, Horvath KD, Marvin MR, Laird DA, Whelan RL. Increased tumor establishment and growth after open vs. laparoscopic bowel resection in mice. laparoscopic bowel resection in mice. Surg Endosc. 2008 ; 12: 1035-1038
4. Lennard TW, Shenton BK, Borzotta A, et al. The influence of surgical operations on components of the human immune system. Br J Surg. 1985 ; 72: 771-776 (Pubitemid 16193547)
5. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971 ; 285: 1182-1186
6. Shantha Kumara HMC, Feingold D, Kalady M, et al. Colorectal resection is associated with persistent proangiogenic plasma protein changes: postoperative plasma stimulates in vitro endothelial cell growth, migration, and invasion. Ann Surg. 2009 ; 249: 973-977
7. Belizon A, Horst P, Balik E, et al. Persistent elevation of plasma VEGF levels during the first month following minimally invasive colorectal resection. Surg Endosc. 2008 ; 22: 287-297
8. Shantha Kumara HMC, Cabot JC, Yan X, et al. Minimally invasive colon resection is associated with a persistent increase in plasma PlGF levels following cancer resection. Surg Endosc. :
9. Funakoshi H, Nakamura T. Hepatocyte growth factor: from diagnosis to clinical applications. Clin Chim Acta. 2003 ; 327: 1-23 (Pubitemid 35447813)
10. Birchmeier C, Birchmeier W, Gherardi E, Van de Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003 ; 4: 915-925 (Pubitemid 37493640)
11. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun. 1984 ; 122: 1450-1459 (Pubitemid 14073577)
12. Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol. 2005 ; 53: 35-69 (Pubitemid 39656109)
13. Horiguchi N, Takayama H, Toyoda M, et al. Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethyl nitrosamine. Oncogene. 2002 ; 21: 1791-1799 (Pubitemid 34259181)
14. Nakamura T, Matsumoto K, Kiritoshi A, Tano Y, Nakamura T. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions. Cancer Res. 1997 ; 57: 3305-3313 (Pubitemid 27351751)
15. Matsumoto-Taniura N, Matsumoto K, Nakamura T. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts. Br J Cancer. 1999 ; 81: 194-202 (Pubitemid 29423695)
16. Hasina R, Matsumoto K, Matsumoto-Taniura N, Kato I, Sakuda M, Nakamura T. Autocrine and paracrine motility factors and their involvement in invasiveness in a human oral carcinoma cell line. Br J Cancer. 1999 ; 80: 1708-1717 (Pubitemid 29389622)
17. Kominsky SL, Argani P, Korz D, et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene. 2003 ; 22: 2021-2033 (Pubitemid 36523639)
18. Martin TA, Mansel RE, Jiang WG. Regulation of tight junction function by hepatocyte growth factor in human breast cancer cells. Cell Biol Int. 2004 ; 28: 361-371 (Pubitemid 38748926)
19. Jiang WG, Martin TA, Parr C, Davies G, Matsumoto K, Nakamura T. Hepatocyte growth factor, its receptor, and their potential value in cancer therapies. Crit Rev Oncol Hematol. 2005 ; 53: 35-69 (Pubitemid 39656109)
20. Reisinger K, Kaufmann R, Gille J. Increased Sp1 phosphorylation as a mechanism of hepatocyte growth factor (HGF/SF)-induced vascular endothelial growth factor (VEGF/VPF) transcription. J Cell Sci. 2003 ; 116: 225-238 (Pubitemid 36163864)
21. Zhang YW, Su YL, Volpert OV, Van de, Woude GF. Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation. Proc Natl Acad Sci U S A. 2003 ; 100: 12718-12723 (Pubitemid 37339965)
22. Shantha Kumara HMC, Kirman I, Feingold D, et al. Perioperative GMCSF limits the proangiogenic plasma protein changes associated with colorectal cancer resection. Eur J Surg Oncol. 2009 ; 35: 295-301
23. Xin X, Yang S, Ingle G, et al. Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo. Am J Pathol. 2001 ; 158: 1111-1120 (Pubitemid 32221803)
24. Zhang YH, Wei W, Xu H, Wang YY, Wu WX. Inducing effects of hepatocyte growth factor on the expression of vascular endothelial growth factor in human colorectal carcinoma cells through MEK and PI3K signaling pathways. Chin Med J. 2007 ; 120: 743-748 (Pubitemid 46767818)
25. Shimomura T, Kondo J, Ochiai M, et al. Activation of the zymogen of hepatocyte growth factor activator by thrombin. J Biol Chem. 1993 ; 268: 22927-22932 (Pubitemid 23318359)
26. Pennacchietti S, Michieli P, Galluzzo M, Mazzone M, Giordano S, Comoglio PM. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell. 2003 ; 3: 347-361 (Pubitemid 38340304)
27. Fukuura T, Miki C, Inoue T, Matsumoto K, Suzuki H. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer. 1998 ; 78: 454-459 (Pubitemid 28360631)
28. Whitworth MK, Sheen A, Rosa DD, et al. Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor. J Cancer Res Clin Oncol. 2006 ; 132: 41-44 (Pubitemid 41712805)
29. Fan T-P, Warn R, Gherardi E. Hepatocyte growth factor (HGF) and wound healing. Pathophysiology. 1998 ; 5 (suppl 1). 169
30. Bevan D, Gherardi E, Fan TP, Edwards D, Warn R. Diverse and potent activities of HGF/SF in skin wound repair. J Pathol. 2004 ; 203: 831-838 (Pubitemid 38961570)
31. Kirman I, Cekic V, Poltaratskaia N, et al. Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this change. Surgery. 2002 ; 132: 186-192 (Pubitemid 35024760)